Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Norman Payson currently holds 6,689 shares of Evolent Health, Inc. (EVH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Norman Payson has been a net seller of EVH stock. They have purchased $0 and sold $83.1M worth of shares.
Norman Payson's most recent insider trade was on Nov 18, 2025, when they sold 50,265 shares at $0.00 per share.
Norman Payson serves as Executive at Evolent Health, Inc. (EVH). They have executed 745 insider transactions totaling $83.1M over their tenure at the company.
Norman Payson holds the position of Executive at Evolent Health, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Norman Payson has shown a selling trading pattern, with $0 in total purchases and $83.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Norman Payson was on Aug 17, 2022, when they sold $284.6K worth of PGNY shares. This transaction involved 6,518 shares at $43.67 per share.
Norman Payson currently owns 6,689 shares of Evolent Health, Inc. (EVH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Norman Payson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Norman Payson has 745 Form 4 filings on record as an insider at Evolent Health, Inc..
Set alerts for Norman Payson and 40,000+ other insiders.